Does CILTACABTAGENE AUTOLEUCEL Cause Encephalopathy? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Encephalopathy have been filed in association with CILTACABTAGENE AUTOLEUCEL (CARVYKTI). This represents 0.5% of all adverse event reports for CILTACABTAGENE AUTOLEUCEL.
17
Reports of Encephalopathy with CILTACABTAGENE AUTOLEUCEL
0.5%
of all CILTACABTAGENE AUTOLEUCEL reports
7
Deaths
10
Hospitalizations
How Dangerous Is Encephalopathy From CILTACABTAGENE AUTOLEUCEL?
Of the 17 reports, 7 (41.2%) resulted in death, 10 (58.8%) required hospitalization, and 6 (35.3%) were considered life-threatening.
Is Encephalopathy Listed in the Official Label?
Yes, Encephalopathy is listed as a known adverse reaction in the official FDA drug label for CILTACABTAGENE AUTOLEUCEL.
What Other Side Effects Does CILTACABTAGENE AUTOLEUCEL Cause?
Cytokine release syndrome (570)
Pyrexia (242)
Immune effector cell-associated neurotoxicity syndrome (232)
Parkinsonism (209)
Hospitalisation (193)
Adverse event (143)
Neurotoxicity (140)
Death (130)
Malaise (126)
Fatigue (123)
What Other Drugs Cause Encephalopathy?
BACLOFEN (845)
METHOTREXATE (775)
ACETAMINOPHEN (608)
IFOSFAMIDE (585)
CYCLOPHOSPHAMIDE (552)
TACROLIMUS (523)
PREDNISONE (489)
DEXAMETHASONE (428)
METFORMIN (418)
ETOPOSIDE (404)
Which CILTACABTAGENE AUTOLEUCEL Alternatives Have Lower Encephalopathy Risk?
CILTACABTAGENE AUTOLEUCEL vs CIMETIDINE
CILTACABTAGENE AUTOLEUCEL vs CIMZIA
CILTACABTAGENE AUTOLEUCEL vs CINACALCET
CILTACABTAGENE AUTOLEUCEL vs CINNARIZINE
CILTACABTAGENE AUTOLEUCEL vs CINRYZE